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ABSTRACT
Despite the extensive use of Saccharomyces cere-
visiae as a platform for synthetic biology, strain en-
gineering remains slow and laborious. Here, we em-
ploy CRISPR/Cas9 technology to build a cloning-free
toolkit that addresses commonly encountered obsta-
cles in metabolic engineering, including chromoso-
mal integration locus and promoter selection, as well
as protein localization and solubility. The toolkit in-
cludes 23 Cas9-sgRNA plasmids, 37 promoters of
various strengths and temporal expression profiles,
and 10 protein-localization, degradation and solubil-
ity tags. We facilitated the use of these parts via a
web-based tool, that automates the generation of
DNA fragments for integration. Our system builds
upon existing gene editing methods in the thorough-
ness with which the parts are standardized and char-
acterized, the types and number of parts available
and the ease with which our methodology can be
used to perform genetic edits in yeast. We demon-
strated the applicability of this toolkit by optimizing
the expression of a challenging but industrially im-
portant enzyme, taxadiene synthase (TXS). This ap-
proach enabled us to diagnose an issue with TXS
solubility, the resolution of which yielded a 25-fold
improvement in taxadiene production.
INTRODUCTION
The yeast Saccharomyces cerevisiae is an excellent organism
for commercial-scale production of biological molecules
due to its capacity for high-density fermentation, status
as a GRAS (generally regarded as safe) organism, genetic
tractability and the availability of tools for genetic engineer-
ing (1,2). However, strain development remains slow and la-
borious because of difficulties anticipating the combined ef-
fect of different expression parts and conditions. Although
the field of synthetic biology has advanced rapidly in recent
years, the assortment of expression contexts currently used
for heterologous gene expression is limited and poorly char-
acterized. Native genes, on the other hand, are controlled
by a large variety of gene expression parts allowing for dy-
namic responses to environmental signals. Therefore, the
advancement of strain engineering relies on the provision of
more diverse and characterized expression parts that can be
easily combined so that a large number of expression con-
texts can be explored.
Plasmid-based systems are routinely used in S. cerevisiae
to express synthetic pathways. Specifically, 2-micron plas-
mids provide a convenient route for overexpression due
to their high copy numbers. There are, however, signifi-
cant problems associated with plasmids such as variabil-
ity in plasmid copy number between cells and recombi-
national and segregational instability, which make it dif-
ficult to maintain stable unimodal cell populations (1,3).
This heterogeneity can result subpopulations of cells that
don’t express the full pathway at optimal levels. Addition-
ally, plasmid-based systems require selectable markers and
media that can be too expensive for industrial applications.
Genomic integration is therefore often the best method to
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ensure pathway stability and homogeneous expression in a
population.
The recent refactoring of the type II CRISPR (Clustered
Regularly InterSpaced Short Palindromic Repeats) Cas9
(CRISPR-associated protein 9) system for use in genome
editing has enabled more efficient and accessible integra-
tion into the genome. In yeast, this system works by em-
ploying a Streptococcus pyogenes Cas9 endonuclease that
is directed to cleave at DNA sequences specified by a non-
coding single-guideRNA (sgRNA) that works by base pair-
ing with the DNA target sequence, enabling the endonucle-
ase to introduce a site-specific double-stranded break (DSB)
in the DNA (4). The 20-nucleotide guide sequence at the 5′
end of the sgRNA specifies the cut site, and can be designed
to target any site in the genome that contains a protospacer
adjacent motif NGG sequence. TheDSB can be repaired by
homologous recombination (HR), allowing for marker-less
disruption, deletion or insertion (5).
Several groups have demonstrated high-efficiency chro-
mosomal integration of marker-less donor DNA cassette(s)
in S. cerevisiae using Cas9-sgRNA plasmid(s) (1,6–8). A
single DSB introduced by a sgRNA-Cas9 complex allows
for integration of multiple kilobases of DNA into a locus
that can be added as several PCR fragments or oligonu-
cleotides that assemble in vivo by HR (8). Transformation
of multiple sgRNAs can be used to integrate into several
sites simultaneously, allowing for rapid construction of en-
tire metabolic pathways (7–10). After chromosomal edit-
ing, strains can be cured of the Cas9-sgRNA plasmid(s)
and used or modified further. Because integrations using
Cas9 can be marker-less, there is no need for additional
transformations or for marker recycling as is needed in the
Cre/LoxP strategy (11), avoiding associated genome insta-
bility (12). Additionally, cloning inE. coli can be avoided by
using PCR-generated fragments encoding new sgRNA(s)
that assemble with a fixed linear backbone byHR (8). Thus,
the use of Cas9 greatly reduces the time of strain construc-
tion, and vastly increases the capacity for introduction of
modifications.
The improvements in strain construction pipelines af-
forded by CRISPR/Cas9 allow for increased throughput
and flexibility of integration sequences. However, high pro-
duction of target compounds from stable chromosomal in-
tegration also requires proper expression contexts to ob-
tain maximal product levels (13–15). Unfortunately, choos-
ing proper expression context in a systematic manner is
hindered by scant characterization data, little standardiza-
tion of parts andmeasurements (16) and laborious assembly
schemes.
In this study, we developed a Cas9-based toolkit to
quickly institute genetic changes in S. cerevisiae for op-
timizing heterologous gene expression. We characterized
a range of expression programs, including exponential-
or stationary-phase specific expression, subcellular pro-
tein localization to specific organelles, and altered protein
turnover or solubility afforded by gene expression parts.
Our toolkit contains high-efficiency, Cas9-sgRNAplasmids
targeting 23 characterized integration loci, 37 promoters,
10 protein tags and a software tool to design integration
cassettes. We employed our toolkit to optimize the expres-
sion of taxadiene synthase, the first committed enzyme in
a pathway for the production of the anti-cancer compound
paclitaxel, demonstrating the usefulness of our rapid and
expanded workflow for yeast strain engineering.
MATERIALS AND METHODS
Strain and plasmid availability
Escherichia coli and S. cerevisiae strains and DNA se-
quences reported here (Supplementary Tables S3 and S4),
along with their associated information (including anno-
tated sequence files), have been deposited in the public in-
stance of the JBEIRegistry (17) (https://public-registry.jbei.
org/folders/248) and are physically available from the au-
thors. Because Cas9 has been implemented in many of the
S. cerevisiae strains and recent literature cautions the cre-
ation of unintended gene drives upon mating of haploid
yeast (18), all S. cerevisiae strains will be cured of any Cas9
plasmids prior to distribution. In order to keep the biosafety
concern of creating gene drives low in this study, all S. cere-
visiae strains were stored and maintained as haploids.
DNA design and construction
DNA cloning was performed using Gibson assembly (19)
in E. coli, or homologous recombination in S. cerevisiae.
Plasmidswere recovered fromS. cerevisiae by lysing the cells
mechanically using glass beads, followed by plasmid mini-
prep (Qiagen) and transformation of the eluted fraction into
E. coli.
All pCut plasmids were derived from a pRS426 vector
and have a 2  origin of replication and a URA3 marker.
Cas9 is driven by the ADH1 promoter and CYC1 termi-
nator. The sgRNA is driven by a tyrosine promoter with
or without a HDV ribozyme structure, as indicated, and a
SNR52 terminator. For the construction of the taxadiene
synthase (TXS) library, theURA3marker of the pCut plas-
mids was replaced by the LEU2 marker.
For characterizing the effect of promoter and integra-
tion locus on the protein expression level of GFP, promoter
and terminator sequences were picked from the S. cerevisiae
genome, defined as 600 bp upstream of the start codon,
or 250 bp downstream of the stop codon, respectively. For
the locus studies, a yeast enhanced GFP (yeGFP) cassette,
driven by a TEF1 promoter and an ADH1 terminator, was
integrated into each of the sites. For the promoter studies,
a short-half life UbiM-GFP (20) was integrated into the
ARS1021b site, preceded by each of the various promoters
and followed by the ADH1 terminator.
Our CASdesigner web tool was used to design primers to
create donor DNA fragments with 30–60 bp inter-fragment
homology and 1-kbp flanking regions homologous to the
respective target site. BY4742 genomic DNA served as a
template to generate all flanking regions, promoters and
terminator fragments. All other pieces were amplified from
plasmids or from genomic DNA of previously integrated
and sequence confirmed strains.
Strains, media and cultivation conditions
The parent S. cerevisiae strain used for integrating
and characterization of loci, promoters and tags on
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GFP was BY4742 {MAT; his3Δ1; leu2Δ0; lys2Δ0;
ura3Δ0}. The parent S. cerevisiae strain used for inte-
grating and characterizing TXS variants was GTy116
{MATa, leu2-3, 112::HIS3MX6-GAL1p-ERG19/GAL10p-
ERG8; ura3-52::URA3-GAL1p-MvaSA110G/GAL10p-
MvaE (codon optimized); his3Δ1::hphMX4-GAL1p-
ERG12/GAL10p-IDI1; trp1-289::TRP1 GAL1p-
CrtE(X.den)/GAL10p-ERG20; YPRCdelta15::NatMX-
GAL1p-CrtE(opt)/GAL10p-CrtE}.
Promoter and integration locus characterization exper-
iments were conducted in synthetic defined (SD, 0.67%
(w/v) yeast nitrogen base without amino acids (VWR In-
ternational), 0.2% (w/v) complete supplement mixture w/o
yeast nitrogen base (Sunrise Science Products)) or standard
rich media (YP, 1% (w/v) Bacto yeast extract, 2% (w/v)
Bacto peptone) with 2% (w/v) sugar). Pre-cultures for taxa-
diene production were grown in YP-raffinose (YP supple-
mented with 2% (w/v) raffinose.). Production of taxadiene
was performed in YP-galactose (YP supplemented with 2%
(w/v) galactose). E. coliDH10b, used for cloning and plas-
mid amplification, were grown in LB supplemented with
100g/ml carbenicillin.
S. cerevisiae transformation and integration confirmation
S. cerevisiae were transformed by electroporation based on
a previously published protocol (21), using ∼2 × 108 yeast
cells, 100 ng of plasmid and 1 g of donor DNA for each
transformation.When usingmultiple pieces of donorDNA,
equimolar amounts of the fragments were used to a total
of 1 g. When performing gap-repair plasmid cloning, 100
ng of plasmid backbone and 200 ng of DNA encoding the
sgRNAwith 30 bp homology to the backbone on either side
were used for transformation.
Saturated overnight cultures of S. cerevisiae were diluted
to an OD600 of 0.15, and incubated at 30◦C, shaking at 250
rpm until cells reached an OD600 of 0.8 to 1.2. The cultures
were centrifuged for 3 min at 3000 rpm, and the cells were
washed once with 45 ml ice-cold water and once with 45 ml
ice-cold yZap buffer (1 M Sorbitol, 10 mM CaCl2), before
they were resuspended in 20 ml yCondition buffer (0.1 M
LiAc, 1 mMDTT) and incubated for 30 min at 30◦C, shak-
ing at 250 rpm. Afterward, the cells were centrifuged again
for 3min at 3000 rpm and washed once more with 45ml ice-
cold yZap buffer. The resulting cell pellets were resupended
in n × 200 l ice-cold yZap buffer (n = number of transfor-
mations) and stored on ice until use.
A total of 200 l of cells were added to microcentrifu-
gation tubes containing the transforming DNA. The DNA
– cell suspension was added to pre-chilled 2 mm electropo-
ration cuvettes and electroporated at 2.5 kV, 200 mA and
25 F. Immediately after electroporation, samples were re-
suspended in 0.5 ml YPD. After incubation at 30◦C at 200
rpm for 30 min, cells were centrifuged at 10 000 rpm for 1
min and the cells were resuspended in 100 l double dis-
tilled H2O and plated on selective media plates. Plates were
incubated at 30◦C for 2–3 days, until colonies became visi-
ble.
Upon appearance of colonies, integration at the intended
target site was confirmed via directed colony PCR prior
to measurement of GFP or taxadiene levels. Additionally,
all taxadiene strains were completely sequenced at the inte-
grated locus to confirm that the integrated cassette(s) con-
tained no mutations.
Flow cytometry
High-throughput flow cytometry experiments were per-
formed using the Accuri C6 flow cytometer equipped with
an autosampler (BD). Cells were cultivated in 500 l YPD,
CSM or YP-galactose in 96 deep-well plates at 30◦C, 250
rpm for 24 h prior to being diluted to OD600 0.1 in 500 l of
the respective medium and cultivated under the same con-
ditions until fluorescence measurements were performed in
biological triplicate. Immediately before starting the fluo-
rescence measurements, 1 drop of SPHEROTM Rainbow
Calibration Particles (8 peaks, Spherotech, Catalog No:
RCP-30-5A, Lot No: AG01) was added to 100 l of the re-
spective media in an empty well, dispersed and measured
along site the samples to generate a standard curve and al-
low the calculation of molecules of equivalent Fluorescein
(MEFL) values (16). A total of 30 000 events were recorded
at a flow rate of 66 l/min, and a core size of 22 m. GFP
was excited at 478 nm at 70 mW and emission detected at
530 nm. Data acquisition was performed as described in
the Accuri C6 Sampler User’s Guide. The acquired data
were analyzed in the Accuri C6 Sampler software.
Taxadiene production
Strains were grown overnight at 30◦C in 200 l YP-
raffinose, and the resulting cultures were used to inoculate
(to an OD600nm of 0.05) 5 ml YP-galactose production cul-
tures. The production cultures were overlaid with 10% (v/v)
dodecane spiked with an internal standard of 200 mg/l C19
methyl ester (Sigma). A total of 10 l of the dodecane over-
lay was mixed with 90 l of ethyl acetate and analyzed us-
ing GC–MS and a previously described method (22) with
modifications as follows. An initial temperature of 120◦C
was maintained for 3 min, followed by ramping to 250◦C
at a rate of 20◦C/min to 250◦C, and then held at 250◦C for
another 3 min. The total flow was set to 8.3 ml/min and he-
lium flow was set to 1 ml/min. Taxadiene production mea-
surements were performed in biological triplicates or qua-
druplicates. A standard containing known concentrations
if the internal standard and taxadiene obtained from Phil
Baran was used to determine titer.
Integration efficiency
A total of 100 ng pCut plasmid was co-transformed with
1 g of the respective donor DNA as a three-piece gap re-
pair (two 300 ng 1 kbp homology regions and 400 ng GFP
cassette) in biological triplicate. Unless otherwise indicated,
48 clones from each transformation replicate were analyzed
for GFP expression using the Accuri C6 high-throughput
flow cytometer as described above, resulting in 144 clones
analyzed in total for each integration locus.
Growth rate experiments
Saturated overnight cultures of S. cerevisiae grown in 500
l YPD (1% (w/v) Bacto Yeast Extract, 2% (w/v) Bacto
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Peptone, 2% (w/ v) Dextrose) were diluted to an OD600 of
0.1 in 500 l YPD in a 96 deep-well plate and cultivated at
30◦Cwith shaking at 250 rpm. Samples were taken at 0, 4, 8,
12, 24 and 48 h post dilution. OD600 was monitored using a
Synergy 4 (BioTek), preheated to 30◦C.
High performance liquid chromatography (HPLC) analysis
Sugar and metabolite concentrations were quantified on a
1200 series HPLC (Agilent Technologies) equipped with an
Aminex H column. Samples were filtered through 0.45 m
filters (VWR) to remove cells, and 5l of each sample was
injected onto the column, preheated to 50◦C. The column
was eluted with 4 mM H2SO4 at a flow rate of 600 l/min
for 25 min. Sugars and metabolites were monitored by a re-
fractive index detector, and concentrations were calculated
by peak area comparison to known standards.
Experiment data availability
All flow cytometry and gas chromatography mass spec-
trometry data are available from the JBEI Experimental
Data Depot (https://public-edd.jbei.org).
CASdesigner implementation, licensing and availability
CASdesigner is implemented in python 3.4 and third party
libraries including biopython (http://biopython.org), pan-
das (http://pandas.org) and Intermine (http://intermine.
org). CASdesigner is open-source software under the BSD
license (https://opensource.org/licenses/BSD-2-Clause), is
freely available from GitHub (https://github.com/JBEI/
CASdesigner) and is also available through its web interface
on the public CASdesigner webserver (http://casdesigner.
jbei.org).
RESULTS
Chromosomal integration using Cas9–sgRNA plasmids and
toolkit-generated donor DNA
Our approach to chromosomal integration employs
marker-less donor DNA and a single high-copy plasmid
expressing both Cas9 and a sgRNA, henceforth referred to
as pCut-X. In our system, Cas9 is expressed using anADH1
promoter and a CYC1 terminator; the sgRNA using a
tyrosine tRNA promoter (fused to a ribozyme as described
in (1)) and an SNR52 terminator. Our CASdesigner web
tool (described later) was used to design primers to create
donor DNA fragments with 30–60 bp inter-fragment
homology and 1-kbp flanking regions homologous to the
individual chromosomal target site (Figure 1).
Fluorescence intensity varies ∼2-fold across 23 integration
sites
Chromosomal loci are associated with features such as pat-
terns of nucleosome occupancy and histone modification,
timing of DNA replication initiation and availability of
transcription or other factors with known general effects on
gene expression (23,24). Furthermore, the structure of the
sgRNA has been shown to influence the success rate of site-
specific DSB generated by Cas9 (25). While protein expres-
sion from a given site and the Cas9 cleavage efficiency me-
diated by a specific sgRNA are important aspects in strain
engineering, there are few sgRNAs and target chromosomal
sites characterized to date, limiting the wider applicability
of Cas9 technology.
To increase the number of characterized genomic integra-
tion sites for stable expression of heterologous genes in S.
cerevisiae, we generated a set of pCut plasmids and analyzed
integration efficiency and protein expression from a GFP
reporter cassette using flow cytometry. We chose 23 sites
distributed across the 16 S. cerevisiae chromosomes, allow-
ing flexibility and capacity for large numbers of integrations
while minimizing the risk of chromosomal rearrangements
when integrating into multiple loci in parallel. Because of a
suggested link between high expression and replication ini-
tiation, we picked sites near several autonomously replicat-
ing sequences (ARSs) with a range of DNA replication ini-
tiation times including control sites previously reported to
be high-expressing (23,26). The 20-nt guide sequences tar-
geting these sites were chosen from a published list of se-
quences with minimal off-target effects (6). The sites char-
acterized in this study are named according to the neighbor-
ing gene, followed by a letter, with sites near ARSs specified
by the ARS number only (e.g. 208a).
Using our pCut plasmids, we integrated a reporter cas-
sette encoding a green fluorescent protein (GFP, expressed
using a TEF1 promoter and ADH1 terminator) into each
site. The GFP donor DNA was transformed as three pieces
(theGFP cassette and two 1-kb flanking homology regions)
(Figure 2A), and strains were analyzed for fluorescence us-
ing flow cytometry. To extend the applicability of our toolkit
for laboratory and industrially relevant conditions, we per-
formed our assays in rich (Yeast extract Peptone Dextrose
media, YPD) and minimal (Complete Supplement Media,
CSM) media and at two time points representing exponen-
tial and (early) stationary phases (8 and 24 h, respectively).
Because these growth phases are poorly defined, we assayed
optical density at 600 nm (OD600) and extracellularmetabo-
lites HPLC for a wild type strain through time in both min-
imal and rich media to select sampling time points repre-
sentative of the different cell growth phases (Supplementary
Figure S1). In both YPD and CSM, the strains rapidly con-
sumed glucose andwere in active growth by 8 h. InYPD, the
strains consumed all glucose by 24 h, reaching an OD600 of
8.4. In CSM, the strains grewmore slowly and only reached
an OD600 of 3.6, but nevertheless consumed the majority of
glucose by 24 h.We therefore define the cell growth phase at
8 h of cultivation after back dilution as exponential phase,
and 24 h as stationary phase.
In general, we found minimal variation in fluorescence
intensity across all sites within a given condition (Figure 2B
and Supplementary Table S1). Overall, the integration of
GFP into the various sites led to tight distributions of fluo-
rescence intensities for a given population as well as among
different biological replicates (CV < 0.1 among means of
different replicates). Within a given medium, we observed
a moderate decrease in GFP expression as strains transi-
tioned from exponential into stationary phase (3.7-fold in
YPD, 1.9 in CSM). Medium-dependent differences in fluo-
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Figure 1. Cas9-based toolkit for programming gene expression in S. cerevisiae. The toolkit facilitates strain construction by providing characterized
genetic parts that can be used to program gene expression. (A) CASdesigner web-based software assists the researcher in selecting genetic parts based on
the data reported herein and automatically designs the primers required to (B) generate donor DNA fragments with 30–60 bp inter-fragment and 1 kbp
chromosomal homology. The homology regions and a Cas9–sgRNA plasmid (pCut-X) together specify the chromosomal integration site. (C) The sgRNA
contains a 20-nt guide sequence also present in the targeted chromosomal locus (cut site). The cut site is cleaved by the sgRNA–Cas9 complex, then repaired
by donor DNA via HR. (D) The choice of parts can confer different biological activities, here represented using Synthetic Biology Open Language (SBOL)
Visual glyphs (triangles, HR regions; half-circle, ribosome binding site; pentagons pointing to the right, protein-coding sequences; T, terminator; arrow,
promoter; circle connected by dashed line, RNA stability element; circle connected by solid line, protein stability element) following established conventions
(52). (E) By the choice of genetic parts, a gene of interest can be expressed under various expression programs (level, timing, subcellular localization).
rescence intensity can be observed for the sites in exponen-
tial phase: in most cases fluorescence intensity was higher in
YPD, however, 607c and 1414a showed the opposite trend,
and are the only sites conferring slightly higher fluorescence
levels in CSM as compared to YPD. This result could be
due to dynamic regulation in response to environmental sig-
nals, highlighting the need to characterize integration sites
in different conditions. However, several sites stood out as
having higher-than-average expression in all or most con-
ditions tested (208a, 1622b, YPRCdelta15c), and include
the highest-expression site reported in a previous study,
YPRCdelta15 (23).
The slower growth, lower consumption of sugar and
overall diminished fluorescence from integrated GFP cas-
settes in CSM medium supports that CSM may not be a
good medium for bioproduction, and reiterates the need
for genomic integration of pathway genes so that selective
medium is not needed.
Integration efficiency varies by cut site and sgRNA sequence
To explore the impact of the target locus and sgRNA on
integration efficiency, we evaluated the rate of positive in-
tegrations of a GFP cassette into each site using flow cy-
tometry. For each locus, we performed transformations in
triplicate, maintaining the same three-piece design of donor
DNA as previously described (Figure 2A), and identified
positive integrants through analysis of fluorescence inten-
sity.
We observed high integration efficiencies with the major-
ity of our pCut plasmids (Figure 2C). For 13 sites, integra-
tion of the GFP cassette was detected in 80% or more of
the colonies tested; for 10 of these, in 95% or more. Several
of these sites also conferred higher-than-average GFP ex-
pression levels (208a, 308a, 416d, Figure 2 and Supplemen-
tary Table S1). However, in five sites GFP expression was
detected in fewer than 40% of the colonies tested. Two of
these poor-efficiency sites (RDS1a, YOLCdelta1b) are lo-
cated near telomeres, which are known to be associated with
heterochromatin domains that are inaccessible to genomic
integration (27). However, the other three low-efficiency
sites showed no obvious ominous locus features (607c, 805a,
1206a), leading us to hypothesize that the sgRNAs targeting
these sites may be the underlying issue.
The sgRNA expression cassette within pCut contains a
tyrosine tRNA promoter fused to a self-cleaving, genomic
hepatitis delta virus C ribozyme. The addition of the ri-
bozyme to the sgRNA cassette has been shown to increase
sgRNA transcript levels (1).While Ryan et al. achieved high
integration efficiencies using a ribozyme fused to the 5′ end
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Figure 2. Effect of chromosomal locus upon integration efficiency and reporter protein expression. We integrated a GFP reporter cassette into 23 chromo-
somal sites of S. cerevisiae to analyze the integration efficiency and reporter protein expression associated with each locus. (A) The GFP reporter cassette
(PTEF1-GFP-TADH1) was integrated into each site (indicated by pink arrows) using a Cas9-sgRNAplasmid (pCut). (B) GFP fluorescence levels are reported
in NIST-standard molecules of equivalent Fluorescein (MEFL) (16) shown in this plot for strains grown in YPD at 8 h. Data for all other conditions are
available in Supplementary Figure S2. Parent is a BY4742 wild-type strain. The bars represent the mean, and the error bars the standard deviation, for three
to four biological replicates (independently derived colonies). (C) Integration efficiency for each site was quantified from three separate transformations,
using three fragments with 1-kbp homology to the target site and 30–60 bp inter-fragment homology as donor DNA. Bars represent average percent of
positive GFP integrants of 48 clones from each transformation replicate; error bars standard deviation, from three separate transformations.
of their selected sgRNAs, other groups have shown simi-
lar results without a ribozyme (7,8). To test whether the ri-
bozyme fusion negatively impacted the effectiveness of the
low-efficiency pCut plasmids in our set, we cloned any plas-
mid with lower than 40% integration efficiency without the
ribozyme (pCut-r, for sites RDS1a, 1206a, 805a, 607c) and
performed integration efficiency tests with GFP as the re-
porter as described earlier. For each of these sites, integra-
tion efficiency improved at least 2.5-fold when using pCut-
r compared to pCut (Supplementary Figure S3). For site
805a, integration efficiency using pCut-r significantly im-
proved to above 90%. Sites 1206a and 607c, however, re-
mained low-efficiency, suggesting that the guide sequences
are ineffective or that the target regions are inaccessible, and
therefore should not be used for strain engineering.
While the 23 cut sites were chosen from a BY S. cere-
visiae strain background, all 23 sites are also present in both
CEN.PK and W303 backgrounds with two exceptions: (i)
208a is mutated at the fourth nucleotide in CEN.PK, and
(ii) His3b is missing in W303. Therefore, in addition to the
two low efficiency sites, 208a should not be used for strain
engineering in a CEN.PK background and His3b should be
avoided when working in W303.
Previously, it has been shown that Cas9–sgRNA plas-
mid(s) can be transformed as a linear backbone and PCR-
generated fragment(s) containing the sgRNA(s) (8). To as-
sess the possibility of targeting additional chromosomal
sites whilemaintaining a completely cloning-free toolkit, we
compared the integration efficiency of our system using in
vivo gap repair of a linear backbone and sgRNA with 30–
60 bp homology to that obtained using a pre-cloned pCut
plasmid for two of our high-efficiency sites (100% efficiency
with pre-cloned pCut, 106a and 911b). While colony num-
bers decreased by 30% when using in vivo gap repair, inte-
gration efficiency only decreased by 15% (Supplementary
Figure S4). Because the backbone can be generated ahead
of time, and the sgRNA quickly in one round of PCR, this
strategy allows for integrating cassettes without cloning any
plasmids, and retains our rapid pipeline even for targeting
a new chromosomal site.
To assess the impact of integrating a standardized cas-
sette into the different loci characterized in this study on cell
physiology, we tested each GFP integrated strain (as previ-
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ously described above) for growth defects over the course of
48 h in YPD. None of the strains showed any growth defi-
ciencies in YPD media as compared to the parental wild-
type strain (data not shown). We also verified that the se-
lected cut sites did not lie in any 5′ or 3′ UTRs of neigh-
boring genes to decrease the risk of unintentionally affect-
ing regulatory processes (28). No cut sites were found in
any UTRs, but four sites do cut in genes (208a-ECM15,
SAP155b-SAP155, CAN1y-CAN1 and 1114a-YKR05c).
The cut sites 208a, and 1114a lie in putative genes or se-
quences that code for non-essential proteins of unknown
function. The SAP155b sgRNA guides Cas9 to cut in a pro-
tein that functions with the Sit4 phosphatase. The cut site
Can1y is located in an arginine permease gene and was se-
lected as a control because it was studied in a previous inves-
tigation (6). To aid users in cut site choice, annotated gene
bank files of the 2.5 kb genomic region surrounding each
cut site can be found as an attachment to each pCut plas-
mid file on the JBEI Registry (https://public-registry.jbei.
org/folders/248).
Standardized promoters follow awide range of expression lev-
els at various growth phases and media
In yeast, the term ‘promoter’ is frequently used to refer to
sequences upstream of a protein-coding gene including the
5′ untranslated region, by arbitrary demarcation. These re-
gions can affect transcription as well as mRNA subcellular
localization (29) and stability (30), and thus are major de-
terminants of gene expression. Native promoters are known
to mediate a wide range of expression levels (31,32) and
condition-specific activities, and can additionally be eas-
ily amplified from genomic DNA. However, there is little
agreement on what sequences constitute a promoter and lit-
tle characterization data in different commonly usedmedia,
or in growth phases other than exponential. Because we ex-
pected they would allow a wide set of expression programs,
we made native yeast promoters the largest set of gene ex-
pression parts in the toolkit.
We selected 37 native promoters expected to cover var-
ious expression levels and programs (e.g. glycolysis, TCA
cycle, stress response) based on the ontological annotations
of their genes. We defined each promoter as the 600 bp up-
stream of the ATG start site of its corresponding coding
sequence, observing that these regions generally contain all
or most regulatory sequences controlling transcription (33).
Following a standardized assembly scheme, we integrated
these promoter sequences into a fixed locus (1021b) using
a fixed reporter cassette. Because long-lived reporters could
mask decreases in transcriptional activity, we used an N-
degron GFP (UbiM-GFP) with a protein half-life of ∼1.5
h (versus>36 h for wild type GFP) (20) as our reporter. Ex-
pecting possible temporal changes in expression from our
promoter strains, we assayed GFP fluorescence via flow cy-
tometry at additional time points (4, 8, 24 and 48 h) com-
pared to the previous experiment (8 and 24 h). We also as-
sayed activity in Yeast extract Peptone Galactose medium
(YPG), which is used to induce the widely used PGAL1 pro-
moter, to examine how the latter and other promoters be-
haved in these conditions.
Figure 3. Promoters allow a range of expression levels and profiles across
different media and growth phases. We examined 37 promoters driving the
expression of a short half-life GFP reporter (20) integrated into a fixed
chromosomal site in various conditions. The GFP reporter was fused to an
N-degron tag containing ubiquitin (Ubi) followed by amethionine residue.
GFP fluorescence levels of promoters in cells growing in YPD medium
at exponential phase (4 h after dilution) are reported in NIST-standard
MEFL units (16). Data for all other conditions are available in Supple-
mentary Figure S5 and Table 1. The bars represent the mean, and the error
bars the standard deviation, for three to four biological replicates.
Generally, all promoters led to tight unimodal GFP flu-
orescence distributions (CV < 0.1 among means of differ-
ent replicates, <1 among cells within a biological sample)
with means spanning a ∼100-fold dynamic range, differing
by media and time (Figure 3 and Table 1). In most condi-
tions, PTDH3 (a widely used, high-activity promoter from
a glycolytic enzyme) and several other promoters associ-
ated with glycolysis and translation (PTEF1, PPGK1, PTEF2,
PENO2) produced the highest fluorescence levels, matching
previous reports (31). Of these, PPGK1 provided the most
constant activity through time and media. The highest flu-
orescence levels were observed for PGAL1 (natively driving
the gene encoding galactokinase), but only in rich galac-
tose medium at 8 h. In these conditions, PGAL1 fluorescence
was 2.3-fold higher than that of the second most active pro-
moter (PTDH3). However, fluorescence from PGAL1 rapidly
decreased ∼6.3-fold during stationary phase (going from 8-
to 48-h). Other promoters with high activity in exponential
phase that decreased at later culture times (<0.3-fold from
4- to 48-h) are PCCW12, PTEF1 and PENO2 (from a cell wall
mannoprotein, a translation factor and a glycolytic enzyme,
respectively). PGAL1 and PTEF1 are often employed in syn-
thetic biology, yet our data show these promoters are min-
imally active in stationary phase in the media tested. For-
tunately, our screen found promoters more appropriate for
expression in later growth phases.
In stationary phase, we observed several promoters that
are induced (>3-fold from 4- to 48-h), including PHSP26,
PHSP104 and PSSA1, all annotated to regulate stress-response
genes (Table 1). PHSP26, which yielded some of the highest
fluorescence we observed in any condition or time (>24 h
in rich media), has been observed to mediate cytosolic
localization and active translation upon glucose starva-
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Table 1. Reporter GFP expression from characterized promoters in dif-
ferent conditions
MeanGFP levels for the same promoter strains (integrated into site 1021b)
were measured in different media and time points, subtracted from par-
ent and normalized to the highest observedMEFL value in YPD (21 200).
Several promoters with low activity (<0.05 in all conditions) are not shown
here for clarity. YPD, Yeast extract Peptone Dextrose medium; CSM,
Complete Supplement Medium; YPG, Yeast extract Peptone Galactose
medium; Fold refers to the mean GFP value at 48 h divided by that at 4 h,
all in YPD; except for GAL1, where it refers to YPG values at 48 h divided
by that at 8 h.
tion, when most other transcripts are sequestered in non-
translating foci (29). To our knowledge, this promoter has
never been used in a synthetic biology application. Promot-
ers silenced in stationary phase (<0.3-fold from 4- to 48-h)
include PGAL1 (induced only in galactose media), PCCW12,
PTEF1 and PENO2 (from a cell wall mannoprotein, a transla-
tion factor and a glycolytic enzyme, respectively).
Developing a set of localization and other protein tags using
a modular linker
Protein motifs are known to affect important parame-
ters such as stability and subcellular localization. Subcel-
lular targeting, for example, is observed for several native
metabolic pathways (e.g. TCA cycle, -oxidation), expos-
ing an enzyme to different conditions such as concentra-
tions of substrates (or inhibitors), pH or redox cofactors.
Localization tags from native genes have been used to tar-
get heterologous (or native) enzymes to specific organelles
as a way to increase local enzyme concentration and im-
prove titers (34,35). However, fusion tags can be laborious
to design and assemble since they require understanding
of protein trafficking and are therefore not used to their
fullest extent in synthetic biology. To alleviate this obstacle,
we developed a modular framework through which a vali-
dated tag can be attached, N- or C- terminally, to a target
protein using a flexible six-glycine linker (gly6). Based on
previous reports, we chose tags targeting various subcellu-
lar locations (20,34,36–41) to attach to a reporter GFP to
validate their activity (Supplementary Table S2). We con-
structed these localized-GFP strains using a fixed expres-
sion context (site 208a, PTEF1 and TADH1) and visualized
localization by confocal microscopy.
Gratifyingly, all but one of our tags led to the expected
subcellular localization pattern (Figure 4). The only excep-
tion was the vacuolar tag VC1, which appeared to inter-
fere with vesicle trafficking. For tag ER2, we observed GFP
localization patterns resembling proliferations of the ER
membrane, which have been observed after overexpression
of ER proteins such as HMG-CoA reductase (42). Because
these tags conferred their native localization on GFPp, the
data suggest that they can be used to specify the subcellular
localization of heterologous proteins of interest.
Solubility and N-degron tags change the expression level of
GFP
When expressing heterologous proteins, insolubility and ac-
cumulation in inclusion bodies resulting in inactivity is a
common problem. It has been shown that fusion to a sol-
uble protein can often improve solubility. In E. coli, pro-
teins such as the maltose binding protein (MBP) are rou-
tinely fused to heterologous proteins to improve solubility.
However, to our knowledge, MBP has not been tried as a
solubility tag in yeast. We therefore tested this by attaching
a yeast codon-optimized version of the E. coli MBP cod-
ing sequence to the C-terminus of GFP. This led to an 18%
increase in GFP fluorescence levels as measured by flow cy-
tometry (data not shown).
In addition to solubility, the activity of a heterologous
protein is affected by its stability. Earlier we utilized an N-
degron tag in our promoter studies that modulates protein
degradation rate by the N-end Rule (NER, (43)). Linear fu-
sions of Ubi to target proteins are cotranslationally cleaved
by deubiquitylases at the last residue of Ubi, making it pos-
sible to dictate the rate of protein degradation by produc-
ing, in vivo, different residues at the N-termini of other-
wise identical proteins (44). Residues such as glutamate are
known to be destabilizing by the NER; ones such as ser-
ine stabilizing. These N-degron tags can be used to alter the
steady-state expression level of a protein of interest while
maintaining the regulatory dynamics afforded by a given
promoter or terminator.
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Figure 4. Subcellular localization of GFP can be modified using protein tags. We examined the effect of localization tags fused through a universal six-
glycine linker, N- or C- terminally, to aGFP reporter integrated into chromosomal site 208a. Subcellular localization patterns of GFP appended to different
localization tags (Supplementary Table S2) as imaged by confocal fluorescence microscopy.
CASdesigner web-based software facilitates characterization
data visualization and semi-automated donor DNA design
and construction
To simplify the workflow of constructing integration cas-
settes based on our characterization data, we developed a
web tool, Computer-Aided Strain designer (CASdesigner,
http://casdesigner.jbei.org). Our python-based tool guides
users with simple in-line instructions to choose parts and
automatically designs the primers required to construct
donor DNA. CASdesigner can be used to design cassettes
targeting any of our characterized chromosomal sites, us-
ing any of our promoters or tags. Terminators or promoters
for any native S. cerevisiae gene not included in this study
can also be retrieved and incorporated into the design. In
all cases, promoters are defined as the 600 bp upstream of
the start codon, and terminators as the 250 bp downstream
of the stop codon. CASdesigner also allows targeting any
native gene by its common name, allowing deletions or re-
placements. Tools for choosing sgRNA sequences are re-
ported elsewhere (45). SeeMaterials andMethods for CAS-
designer implementation details, licensing and availability.
Building an expression context library for a problematic en-
zyme, taxadiene synthase
Our toolkit can be used to express proteins and pathways
with a diverse set of programs, including exponential- or
stationary-phase specific expression, subcellular targeting
to various organelles and altered protein turnover or solu-
bility. As a demonstration of its utility, we use this context-
diversity approach that employs an exploratory set of parts
aimed at solving common expression problems to quickly
diagnose and address poor activity of an enzyme.
For our test enzyme, we chose TXS that converts the
isoprenoid pathway intermediate geranylgeranyl pyrophos-
phate (GGPP) into taxa-4(5),11(12)-diene, the first commit-
ted intermediate in a pathway producing paclitaxel, a pow-
erful and widely used cancer drug (46) (Figure 5A). Both
paclitaxel and taxadiene have only been identified in conif-
erous trees of the genusTaxus. Because tree harvesting is un-
sustainable, there have been a number of attempts to build
paclitaxel pathways in S. cerevisiae over the last decade, al-
though titers remain <10 mg/l (47).
For our TXS library, we constructed strains using a rep-
resentative subset of parts that explore a wide set of expres-
sion contexts, with 10 protein tags and 5 promoters (Figure
5). These include localization tags (MT1, PM1, ER1, ER2,
PM1), a stabilizing UbiS tag, N- and C-terminal MBP tags
for solubility and N- and C-terminal GFP tags to visualize
subcellular localization. Our tags were fused to TXS using
the gly6 linker, expressed from site 1014a, using PTDH3 and
TADH1. We also built strains containing untagged TXS ex-
pressed from various promoters, including a low-, medium-
and high-strength promoter (PHHF1, PTEF1 and PTDH3, re-
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Figure 5. Diversity context library to optimize Taxadiene Synthase activity. (A) Taxadiene synthase (TXS) catalyzes the cyclization of geranylgeranyl-
pyrophosphate (GGPP) into taxadiene, an intermediate in a pathway to produce the cancer drug Paclitaxel. (B) C- and N-terminal GFP tags attached
to TXS show punctate subcellular localization consistent with poor TXS solubility. (C) Gas chromatography-mass spectroscopy (GC-MS) analysis was
used to quantify the production of taxadiene in strains expressing TXS in our diversity-context library. Shown is the fold-change in taxadiene titer over
the production of the baseline strain (untagged PTDH3–TXS). The bars represent the mean, and the error bars the standard deviation, for three to four
biological replicates.
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spectively), a stress-responsive promoter (PHSP26) and an
inducible promoter (PGAL1). The untagged, PTDH3-driven
TXS strain served as a baseline level of taxadiene pro-
duction on which to improve. All TXS cassettes were in-
troduced into GTy116, a strain in which all enzymes in
the pathway from acetyl–CoA to GGPP are overexpressed
(Supplementary Figure S6).
MBP tags on TXS improve taxadiene production
First, we visualized both C- and N-terminal GFP fusions
of TXS to examine protein expression and subcellular lo-
calization by confocal microscopy (Figure 5B). Both GFP
fusions to TXS formed punctate foci, suggesting poor sol-
ubility. To examine if changing expression contexts led to
any improvements in taxadiene production, we performed
small-scale fermentations in parallel for our TXS strains
and analyzed taxadiene levels by gas chromatography-mass
spectroscopy (Figure 5C). The parent strain used for the
construction of the taxadiene producer strains, GTy116,
did not produce any detectable taxadiene (data not shown).
In all our TXS strains, we observed a peak, which was
not present in our parent strain, that matched the pub-
lished fragmentation pattern of taxadiene (46) (Supplemen-
tary Figure S7). The baseline production level from our un-
tagged TXS was 0.8 mg/l. Among the promoters tested on
untagged TXS, none showed significant increases in taxadi-
ene production (data not shown).
Consistent with a hypothesized solubility problem as di-
agnosed by confocal microscopy, the addition ofMBP solu-
bility tags led to significant improvements in titer. The high-
est taxadiene production was observed for TXS–MBP, at
15-fold higher than the untagged baseline strain. We hy-
pothesized that the promoter library might be effective with
a more soluble TXS, so we tested the same promoters again
with TXS–MBP. We observed a trend of increasing taxadi-
ene titer with increasing promoter strength (as measured for
our GFP promoter strains in YPGal at exponential phase),
reaching a 25-fold improvement for the PGAL1-TXS-MBP
strain to 20 mg/l taxadiene (Figure 5C and Supplementary
Figure S8).
DISCUSSION
In the present study, we describe a methodology and cor-
responding toolkit that allows for rapid and easy genetic
modification for strain engineering in S. cerevisiae. We pro-
vide an extensive integration plasmid library allowing for
high-efficiency integration into 23 characterized genomic
loci, many of which allow for integration efficiencies above
95% (Figure 2C). In vivo assembly of sgRNAs into Cas9
plasmids afforded integration rates just below that of pre-
cloned plasmids, allowing users to easily choose their own
integration sites without the need for cloning (Supplemen-
tary Figure S4).
In our work, most integration sites led to similar GFP
expression levels, with only a ∼2-fold range in protein ex-
pression (as measured by fluorescence, Figure 2B), in agree-
ment with a recent report examining 11 integration loci (48).
A previous study examining reporter protein cassettes inte-
grated at various chromosomal sites report a slightly larger
(∼10-fold) range in expression level using an assay based
on -galactosidase activity (23). Other recent reports ob-
serve that locus effects carry over to different expression cas-
settes, with the locus accounting for 35% (as measured by
qRT-PCR) or 90% (asmeasured by fluorescence) of changes
in observed expression, making our findings generalizable
for other heterologous genes (24,49). The differences in ob-
served expression level of the reporter protein could be ac-
counted for by the different methods of analysis employed
in these studies, as well as choice of sites within an individ-
ual study (e.g. intergenic versus intragenic), highlighting the
need to use standardized measurements units to quantify
expression, as we did.
While the majority of the sgRNAs in our pCut library
initially resulted in high-efficiency integrations (Figure 2C),
removal of the ribozyme structure from the sgRNA resulted
in a dramatically increased rate of integration for one of the
low-efficiency sites (805a, Supplementary Figure S3). Ad-
ditionally, two other sgRNAs led to low rates of integra-
tion with or without the ribozyme (1206a and 607c). A pre-
vious study has examined the chromosomal landscape of
nucleosome-dependent gene expression in yeast using a hi-
stone depletion assay, and charted expression changes for
each gene post depletion (50). We examined the landscape
for each of our failed cut sites and found that 1206a is more
than 5 kb away from any hypothesized heterochromatic re-
gion, while 607c lies in a region of gene upregulation after
depletion. These results suggest that the 607c sgRNA may
not function because it lacks access to the DNA due to het-
erochromatic structure, whereas 1206a may have folding or
other issues with the sgRNA itself.
Nonetheless, clearly factors beyond off-target effects
need to be considered for optimal sgRNA design, such as
sgRNA folding, transcription and degradation, which are
excellent topics for future investigation. Furthermore, the
impact of locus features such as chromatin structure on the
efficiency of genomic integration (51) by potentially affect-
ing accessibility to the sgRNA–Cas9p complex and HR re-
pair machinery requires further research and elucidation.
This study is the first to integrate temporal resolution
of parts activity across different conditions in a systematic
manner. Much of chemical production (especially during
batch fermentation) occurs in stationary phase where there
is little to no characterization of promoters and other ex-
pression parts. Becausewe tested various growth phases and
media, our investigation led to several novel findings. While
PGAL1 is considered one of the highest-expressing promot-
ers in S. cerevisiae, its activity drops significantly at later
stages of growth (Table 1). Using a GFP reporter cassette,
we identified six promoters that resulted in fluorescence lev-
els higher than that of PGAL1 in stationary phase (PHSP26,
PSSA1, PPCK1, PHSP82, PHSP104, PADH2). Of particular note is
PHSP26, which is barely active in exponential cells yet reaches
among the highest expression levels of any condition at sta-
tionary phase. Growth phase-specific activity may be desir-
able in certain synthetic biology designs, including strategies
for growth-decoupled stationary phase production, or tem-
porally separating enzyme activities that are incompatible.
Additionally, we identified several other high-strength
promoters not examined in other studies, including PENO2,
PRPL3, PTPI1 and PYEF3, as well as several stationary phase-
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induced promoters (PHSP26, PSSA1, PPCK1, PHSP82, PHSP104
and PADH2). A handful of the promoters chosen for this
study were also tested in exponential phase in another
recent investigation and rank similarly in protein expres-
sion strength (PTDH3, PCCW12, PTEF1, PTEF2, PPGK1, PHHF2,
PHHF1) as determined by fluorescence (31).
The toolkit described in this work provides a rapid ap-
proach to examine multiple gene expression contexts simul-
taneously, thus increasing the chances of improving activity
even in the absence of complete biological understanding.
To demonstrate its utility, we applied this context-diversity
approach to diagnose and address poor activity for the en-
zyme TXS (Figure 5A). Yeast TXS activity is especially de-
sirable since many of the paclitaxel-pathway steps down-
stream of TXS involve cytochrome P450s, notoriously dif-
ficult to express in E. coli. Using our toolkit, we were able
to show that protein solubility was limiting for TXS activity
in yeast (Figure 5). By constructing TXS–MBP fusion pro-
teins, we achieved a 25-fold improvement in taxadiene titer.
MBP tags have been previously used in yeast for affinity pu-
rification, however, this is the first study to show that the
MBP tag can also be used to increase protein solubility in
S. cerevisiae. A similar methodology could help to identify
and resolve other limiting parameters such as poor intracel-
lular localization or protein degradation for other enzymes,
and be a generalizable approach to optimize expression con-
texts of heterologous enzymes.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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